Rare Heart Surgery at Medicover Hospital, Hyderabad

Hyderabad: A forty five-year-old man who’s working in an IT software program firm in Bengaluru acquired a brand new lease of life after a crew of cardiologists at Medicover Hospitals, right here, carried out a crucial coronary heart process utilizing US Food and Drug Administration (FDA) permitted non-surgical pump technology.

Madhu had undergone a renal transplant in 2002. He was recognized to have a failing transplant and failing coronary heart pumping in 2018 for which he underwent a coronary angiogram, which confirmed triple vessel disease with persistent complete blockage of two vessels.

His repeated admissions in a hospital within the UAE for coronary heart failure stabilisation didn’t assist and he couldn’t plan for a second transplant as a consequence of extreme coronary heart failure. It was in this situation that he was offered at Medicover Hospitals.

After going by way of his complete medical profile, the crew of medical doctors led by Dr A Sharath Reddy, Director-Interventional Cardiologist, and Dr Kamal Kiran, Nephrologist determined to carry out percutaneous intervention for his coronary heart blood vessel blockages utilizing hemodynamic assist with a percutaneous left ventricular help system (Impella).

The crew carried out percutaneous intervention for more than 5 hours by putting a novel percutaneous Left Ventricular assist device-Impella CP-prior to the process, which maintains the regular cardiac output of more than 3.4L giving the interventionist sufficient time to meticulously work on his occluded blood vessels.

“Impella is the only US FDA-approved non-surgical heart pump technology. It is mainly indicated in patients with severe heart disease with other health conditions requiring high-risk PCI. It is the safest and most effective heart pump for critical individuals,” Dr.Sharath Reddy, Director-Interventional Cardiologist stated in an announcement.

“Impella guided PCI procedure ensures good blood flow to all organs including the heart enabling the operator to perform a procedure without any hassles while reducing the need for prolonged hospitalisation and multiple procedures,” Dr.Reddy added.

Post-procedure, the team of doctors observed his condition for one and half days, after which he was discharged in a stable condition. Post-recovery Madhu is doing well and sleeping uninterrupted at nights as his heart is performing greatnow, the doctors stated.

Media Coverage:

https://timesofindia.indiatimes.com/city/hyderabad/rare-surgery-at-city-hospital/articleshow/82643875.cms

https://telanganatoday.com/hyderabad-hospital-saves-life-with-us-fda-approved-non-surgical-pump-technology

https://hydnews.in/hyd-hospital-saves-life-with-us-fda-approved-non-surgical-pump-technology/

https://www.ianslive.in/index.php?param=news/Hyd_hospital_saves_life_with_US_FDA_approved_non_surgical_pump_technology-784982/Latest%20News/31

https://www.khaskhabar.com/local/andhra-pradesh/hyderabad-news/news-hyd-hospital-saves-life-with-us-fda-approved-non-surgical-pump-technology-news-hindi-1-478364-KKN.html

https://deccan.news/hyd-hospital-saves-lives-with-us-fda-approved-non-surgical-pump-technology/